Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Registries »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Regional Blood Flow < Registries < Regression Analysis  Facettes :

List of bibliographic references indexed by Registries

Number of relevant bibliographic references: 67.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000571 (2020) Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon ChoeAssociation between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000653 (2019) Lianne Kearsley-Fleet [Royaume-Uni] ; Sunil Sampath [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
000881 (2019) Kathrine Lederballe Gr N [Oman] ; Elizabeth V. Arkema [Suède] ; Bente Glintborg [Danemark] ; Frank Mehnert [Danemark] ; Mikkel Stergaard [Danemark] ; Lene Dreyer [Danemark] ; Mette N Rgaard [Danemark] ; Niels Steen Krogh [Danemark] ; Johan Askling [Suède] ; Merete Lund Hetland [Danemark]Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
000902 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
000A29 (2019) G. Carlino [Italie] ; M. Fornaro ; L. Santo ; R. Bucci ; A. Semeraro ; L. Quarta ; F. D'Onofrio ; A. Marsico ; C. Zuccaro ; P C Falappone ; D. Mazzotta ; F P Cantatore ; M. Muratore ; F. IannoneOccult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).
000D57 (2019) Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Deshire Alpizar-Rodriguez [Suisse] ; Catalin Codreanu [Italie] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Maria J. Santos ; Cem Gabay [Suisse] ; Axel Finckh [Suisse] ; Delphine S. Courvoisier [Suisse]Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution.
001076 (2018) F. Proft [Allemagne] ; H. Schulze-Koops [Allemagne] ; M. Grunke [Allemagne] ; E. Schrezenmeier [Allemagne] ; F. Halleck [Allemagne] ; J. Henes [Allemagne] ; L. Unger [Allemagne] ; E. Schmidt [Allemagne] ; C. Fiehn [Allemagne] ; A. Jacobi [Allemagne] ; C. Iking-Konert [Allemagne] ; C. Kneitz [Allemagne] ; R E Schmidt [Allemagne] ; B. Bannert [Allemagne] ; R E Voll [Allemagne] ; R. Fischer-Betz [Allemagne] ; I. Kötter [Allemagne] ; H P Tony [Allemagne] ; J. Holle [Allemagne] ; M. Aringer [Allemagne] ; A. Erler [Allemagne] ; F. Behrens [Allemagne] ; G R Burmester [Allemagne] ; T. Dörner [Allemagne][Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)].
001077 (2018) C. Fiehn [Allemagne] ; L. Unger [Allemagne] ; H. Schulze-Koops [Allemagne] ; F. Proft [Allemagne] ; J C Henes [Allemagne] ; A. Jacobi [Allemagne] ; T. Dörner [Allemagne][Rituximab for the treatment of poly- and dermatomyositis : Results from the GRAID-2 registry].
001078 (2018) J C Henes [Allemagne] ; H. Schulze-Koops [Allemagne] ; M. Witt [Allemagne] ; H P Tony [Allemagne] ; F. Mueller [Allemagne] ; M. Grunke [Allemagne] ; M. Czihal [Allemagne] ; T. Dörner [Allemagne] ; F. Proft [Allemagne][Off-label biological therapies in patients with large vessel vasculitis and/or polymyalgia rheumatica : Safety and efficacy analysis of a nationwide German registry (GRAID2)].
001079 (2018) N. Venhoff [Allemagne] ; F. Proft [Allemagne] ; H. Schulze-Koops [Allemagne] ; J. Holle [Allemagne] ; R E Voll [Allemagne] ; C. Iking-Konert [Allemagne] ; A M Jacobi [Allemagne] ; J. Henes [Allemagne] ; L. Unger [Allemagne] ; O. Kneitz [Allemagne] ; T. Dörner [Allemagne] ; J. Thiel [Allemagne][Off-label biologic therapy of ANCA-associated and non-ANCA-associated small-vessel vasculitis : Efficacy and safety analysis of a national registry (GRAID2)].
001205 (2018) Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
001206 (2018) Andrew I. Rutherford [Royaume-Uni] ; Sujith Subesinghe [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] ; James B. Galloway [Royaume-Uni]Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
001221 (2018) Gablu Kilcher [Suisse] ; Noemi Hummel [Suisse] ; Eva M. Didden [Suisse] ; Matthias Egger [Suisse] ; Stephan Reichenbach [Suisse]Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries.
001235 (2018) F. Iannone [Italie] ; G. Ferraccioli [Italie] ; L. Sinigaglia [Italie] ; E G Favalli [Italie] ; P. Sarzi-Puttini [Italie] ; F. Atzeni [Italie] ; R. Gorla [Italie] ; C. Bazzani [Italie] ; M. Govoni [Italie] ; I. Farina [Italie] ; E. Gremese [Italie] ; A. Carletto [Italie] ; A. Giollo [Italie] ; M. Galeazzi [Italie] ; R. Foti [Italie] ; L. Bianchino [Italie] ; L. La Grasta [Italie] ; G. Lapadula [Italie]Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
001264 (2018) Thomas Frisell [Suède] ; Eva Baecklund [Suède] ; Karin Bengtsson [Suède] ; Daniela Di Giuseppe [Suède] ; Helena Forsblad-D'Elia [Suède] ; Johan Askling [Suède]Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
001300 (2018) Alexander G S. Oldroyd [Royaume-Uni] ; Deborah P M. Symmons [Royaume-Uni] ; Jamie C. Sergeant [Royaume-Uni] ; Lianne Kearsley-Fleet [Royaume-Uni] ; Kath Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Long-term persistence with rituximab in patients with rheumatoid arthritis.
001301 (2018) Lisa Baganz [Allemagne] ; Adrian Richter [Allemagne] ; Jörn Kekow [Allemagne] ; Arnold Bussmann [Allemagne] ; Andreas Krause [Allemagne] ; Carsten Stille [Allemagne] ; Joachim Listing [Allemagne] ; Angela Zink [Allemagne] ; Anja Strangfeld [Allemagne]Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
001339 (2018) William Terreaux [France] ; Claire Masson [France] ; Jean-Paul Eschard [France] ; Thomas Bardin [France] ; Arnaud Constantin [France] ; Loïc Le Dantec [France] ; Christian Marcelli [France] ; Aleth Perdriger [France] ; Claire Scotto Di Fazano [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Jean-Hugues Salmon [France]Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE.
001358 (2018) M. Bielak [Allemagne] ; E. Husmann [Allemagne] ; N. Weyandt [Allemagne] ; J-P Haas [Allemagne] ; B. Hügle [Allemagne] ; G. Horneff [Allemagne] ; U. Neudorf [Allemagne] ; T. Lutz [Allemagne] ; E. Lilienthal [Allemagne] ; T. Kallinich [Allemagne] ; K. Tenbrock [Allemagne] ; R. Berendes [Allemagne] ; T. Niehues [Allemagne] ; H. Wittkowski [Allemagne] ; E. Wei Barth-Riedel [Allemagne] ; G. Heubner [Allemagne] ; P. Oommen [Allemagne] ; J. Klotsche [Allemagne] ; Dirk Foell [Allemagne] ; E. Lainka [Allemagne]IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).
001444 (2018) Kim Lauper [Suisse] ; Dan C. Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Maria Victoria Hernández [Espagne] ; Tore K. Kvien [Norvège] ; Eirik Klami Kristianslund [Norvège] ; Maria Jose Santos [Portugal] ; Žiga Rotar [Slovénie] ; Florenzo Iannone [Italie] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Sara L. Gale [États-Unis] ; Khaled Sarsour [États-Unis] ; Yves Luder [Suisse] ; Delphine Sophie Courvoisier [Suisse] ; Cem Gabay [Suisse]Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
001477 (2018) Peter A. Nigrovic [États-Unis] ; Timothy Beukelman [États-Unis] ; George Tomlinson [Canada] ; Brian M. Feldman [Canada] ; Laura E. Schanberg [États-Unis] ; Yukiko Kimura [États-Unis]Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Registries" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Registries" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Registries
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021